Literature DB >> 9241704

Risk factors for venous thrombosis: prevalence, risk, and interaction.

F R Rosendaal1.   

Abstract

Annually, 1 in 1,000 individuals is affected by venous thrombosis. Risk factors that are known to increase the risk of thrombosis may be either genetic or acquired, or have a combined origin. Many of these risk factors are very frequent, among which several have been recently identified, such as resistance to activated protein C by factor V Leiden, hyperhomocysteinemia, high levels of factors VIII, as well as the classical acquired risk factors, such as surgery and malignancies. When the prevalence of risk factors is high, it becomes likely that in some individuals two or more risk factors will be present simultaneously. The question "What happens to the risk in these circumstances?" is one involving interaction, also known as effect modification or synergy. In this article we review the prevalence and risk estimates for the various genetic and acquired risk factors for venous thrombosis, discuss the concept of interaction, and give an overview of the evidence for interaction of these risk factors.

Entities:  

Mesh:

Year:  1997        PMID: 9241704

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  29 in total

1.  Long homozygous chromosomal segments in reference families from the centre d'Etude du polymorphisme humain.

Authors:  K W Broman; J L Weber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 2.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

Review 3.  Thrombophilia: a genetic predisposition to thrombosis.

Authors:  R A Sacher
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

4.  Fatal pulmonary embolism: a study of genetic and acquired factors.

Authors:  K J Slovacek; A F Harris; J F Greene; A Rao
Journal:  Mol Diagn       Date:  2000-03

5.  5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.

Authors:  Y Ozkul; C Evereklioglu; M Borlu; S Taheri; M Calis; M Dündar; O Ilhan
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

6.  Sarcoidosis as a risk factor for venous thromboembolism.

Authors:  Anna Goljan Geremek; Witold Tomkowski; Marcin Geremek; Elżbieta Puścińska; Grzegorz Małek; Adam Nowiński; Michal Bednarek; Paweł Śliwiński
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

7.  The effect of IL-4 and MTHFR gene variants in ankylosing spondylitis.

Authors:  S Yigit; A Inanir; S Tural; B Filiz; A Tekcan
Journal:  Z Rheumatol       Date:  2015-02       Impact factor: 1.372

8.  Thrombophilia in ischemic stroke.

Authors:  A Potti; K M Rabadi; D D Willardsen
Journal:  West J Med       Date:  1998-12

9.  [Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; P Hellstern; W Miesbach; T Kohnen; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

10.  Single-nucleotide polymorphism genotyping on optical thin-film biosensor chips.

Authors:  Xiao-Bo Zhong; Robert Reynolds; Judith R Kidd; Kenneth K Kidd; Robert Jenison; Richard A Marlar; David C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.